{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T23:59:11Z","timestamp":1780963151370,"version":"3.54.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000},"content-version":"vor","delay-in-days":54,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Health Institutes of T\u00fcrkiye (T\u00dcSEB), Affiliated with the Ministry of Health of the Republic of T\u00fcrkiye","award":["11881"],"award-info":[{"award-number":["11881"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-44971-x","type":"journal-article","created":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T18:24:55Z","timestamp":1776363895000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effectiveness and safety of molnupiravir among patients with mild to moderate COVID-19: a prospective, observational, cohort study"],"prefix":"10.1038","volume":"16","author":[{"given":"Serap","family":"\u015eim\u015fek-Yavuz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alpay","family":"Azap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcls\u00fcm","family":"\u00d6zt\u00fcrk-Emiral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00fcsna","family":"\u00c7evik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahmet","family":"G\u00fcner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00fcge","family":"Ayhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belgin","family":"Co\u015fkun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aysun","family":"Benli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye\u015fim","family":"Tok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"\u00d6nel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0130lker","family":"\u0130nan\u00e7-Balkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sezen","family":"Fansa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatma Zehra","family":"G\u00fcne\u015fer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahir","family":"Kapmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilsun","family":"Altunal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elif Selcen","family":"Beng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d6zlem","family":"Ayd\u0131n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sezen \u00d6zge","family":"\u00d6zen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seniha","family":"Ba\u015faran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasan","family":"Ya\u011fmur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meryem","family":"\u00c7al\u0131\u015fkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melek-Nur","family":"Aslan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neslihan","family":"Uyar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burcu Atasoy","family":"Bozan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihriban","family":"Aksoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehtap","family":"Ayd\u0131n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duygu Korkut","family":"Aky\u00fcrek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elif Mukime","family":"Sar\u0131cao\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d6nder","family":"Erg\u00f6n\u00fcl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sevim","family":"Me\u015fe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F\u00fcsun","family":"Can","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mert Ahmet","family":"Ku\u015fkucu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"A\u011fa\u00e7fidan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filiz","family":"Pehlivano\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d6zlem","family":"Altunta\u015f-Ayd\u0131n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alper","family":"G\u00fcnd\u00fcz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,16]]},"reference":[{"key":"44971_CR1","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1056\/NEJMoa2116044","volume":"386","author":"A Jayk Bernal","year":"2022","unstructured":"Jayk Bernal, A. et al. Molnupiravir for oral treatment of Covid-19 in nonhospitalized patients. N. Engl. J. Med. 386, 509\u2013520. https:\/\/doi.org\/10.1056\/NEJMoa2116044 (2022).","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"44971_CR2","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1016\/j.cmi.2024.06.018","volume":"30","author":"W Abu Ahmad","year":"2024","unstructured":"Abu Ahmad, W. et al. Effectiveness and safety of molnupiravir in the intended-use population: An observational cohort study. Clin. Microbiol. Infect. 30 (10), 1305\u20131311. https:\/\/doi.org\/10.1016\/j.cmi.2024.06.018 (2024).","journal-title":"Clin. Microbiol. Infect."},{"issue":"9","key":"44971_CR3","doi-asserted-by":"publisher","first-page":"e2335077","DOI":"10.1001\/jamanetworkopen.2023.35077","volume":"6","author":"DY Lin","year":"2023","unstructured":"Lin, D. Y. et al. Nirmatrelvir or molnupiravir use and severe outcomes from Omicron infections. JAMA Netw. Open 6 (9), e2335077. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.35077 (2023).","journal-title":"JAMA Netw. Open"},{"issue":"6","key":"44971_CR4","doi-asserted-by":"publisher","first-page":"807","DOI":"10.7326\/M22-3565","volume":"176","author":"KL Bajema","year":"2023","unstructured":"Bajema, K. L. et al. Effectiveness of COVID-19 treatment with nirmatrelvir-ritonavir or molnupiravir among U.S. veterans: Target trial emulation studies with one-month and six-month outcomes. Ann. Intern. Med. 176 (6), 807\u2013816. https:\/\/doi.org\/10.7326\/M22-3565 (2023).","journal-title":"Ann. Intern. Med."},{"issue":"9","key":"44971_CR5","doi-asserted-by":"publisher","first-page":"e2020498","DOI":"10.1001\/jamanetworkopen.2020.20498","volume":"3","author":"C Rhee","year":"2020","unstructured":"Rhee, C. et al. Incidence of nosocomial COVID-19 in patients hospitalized at a large US academic medical center. JAMA Netw. Open 3 (9), e2020498. https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.20498 (2020).","journal-title":"JAMA Netw. Open"},{"key":"44971_CR6","unstructured":"WHO R&D Blueprint novel Coronavirus COVID-19 Therapeutic Trial Synopsis. (accessed 25 January 2025); https:\/\/www.who.int\/docs\/default-source\/blue-print\/covid-19-therapeutic-trial-synopsis.pdf (2020)."},{"issue":"37","key":"44971_CR7","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.15585\/mmwr.mm7137a4","volume":"71","author":"S Adjei","year":"2022","unstructured":"Adjei, S. et al. Mortality risk among patients hospitalized primarily for COVID-19 during the Omicron and Delta variant pandemic periods - United States, April 2020-June 2022. MMWR Morb. Mortal. Wkly. Rep. 71 (37), 1182\u20131189. https:\/\/doi.org\/10.15585\/mmwr.mm7137a4 (2022).","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"44971_CR8","doi-asserted-by":"publisher","first-page":"e012328","DOI":"10.1136\/bmjgh-2023-012328","volume":"8","author":"P Relan","year":"2023","unstructured":"Relan, P. et al. Severity and outcomes of Omicron variant of SARS- CoV- 2 compared to Delta variant and severity of Omicron sublineages: A systematic review and metanalysis. BMJ Glob. Health 8, e012328. https:\/\/doi.org\/10.1136\/bmjgh-2023-012328 (2023).","journal-title":"BMJ Glob. Health"},{"issue":"9","key":"44971_CR9","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1093\/jac\/dkad216","volume":"78","author":"M Sun","year":"2023","unstructured":"Sun, M. et al. Molnupiravir for the treatment of non-severe COVID-19: A systematic review and meta-analysis of 14 randomized trials with 34\u200a570 patients. J. Antimicrob. Chemother. 78 (9), 2131\u20132139. https:\/\/doi.org\/10.1093\/jac\/dkad216 (2023).","journal-title":"J. Antimicrob. Chemother."},{"key":"44971_CR10","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1093\/jac\/dkae163","volume":"79","author":"YM Mesfin","year":"2024","unstructured":"Mesfin, Y. M. et al. Effectiveness of nirmatrelvir\/ritonavir and molnupiravir in non-hospitalized adults with COVID-19: Systematic review and meta-analysis of observational studies. J. Antimicrob. Chemother. 79, 2119\u20132131. https:\/\/doi.org\/10.1093\/jac\/dkae163 (2024).","journal-title":"J. Antimicrob. Chemother."},{"issue":"3","key":"44971_CR11","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.jmii.2024.03.002","volume":"57","author":"HA Cheema","year":"2024","unstructured":"Cheema, H. A. et al. Molnupiravir for the treatment of COVID-19 outpatients: An updated meta-analysis. J. Microbiol. Immunol. Infect. 57 (3), 396\u2013402. https:\/\/doi.org\/10.1016\/j.jmii.2024.03.002 (2024).","journal-title":"J. Microbiol. Immunol. Infect."},{"issue":"7","key":"44971_CR12","doi-asserted-by":"publisher","first-page":"e250","DOI":"10.1093\/cid\/ciac724","volume":"78","author":"A Bhimraj","year":"2024","unstructured":"Bhimraj, A. et al. Infectious diseases society of America guidelines on the treatment and management of patients with COVID-19 (September 2022). Clin. Infect. Dis. 78 (7), e250\u2013e349. https:\/\/doi.org\/10.1093\/cid\/ciac724 (2024).","journal-title":"Clin. Infect. Dis."},{"issue":"1","key":"44971_CR13","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1038\/s41467-024-45641-0","volume":"15","author":"JF Standing","year":"2024","unstructured":"Standing, J. F. et al. Randomized controlled trial of molnupiravir SARS-CoV-2 viral and antibody response in at-risk adult outpatients. Nat. Commun. 15 (1), 1652. https:\/\/doi.org\/10.1038\/s41467-024-45641-0 (2024).","journal-title":"Nat. Commun."},{"issue":"8","key":"44971_CR14","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.7326\/M22-0729","volume":"175","author":"MG Johnson","year":"2022","unstructured":"Johnson, M. G. et al. Effect of Molnupiravir on biomarkers, respiratory interventions, and medical services in COVID-19: A randomized, placebo-controlled trial. Ann. Intern. Med. 175 (8), 1126\u20131134. https:\/\/doi.org\/10.7326\/M22-0729 (2022).","journal-title":"Ann. Intern. Med."},{"key":"44971_CR15","doi-asserted-by":"publisher","first-page":"1253799","DOI":"10.3389\/fphar.2023.125379931","volume":"14","author":"Y Liang","year":"2023","unstructured":"Liang, Y. et al. Adverse events associated with molnupiravir: A real-world disproportionality analysis in food and drug administration adverse event reporting system. Front. Pharmacol. 14, 1253799. https:\/\/doi.org\/10.3389\/fphar.2023.125379931 (2023).","journal-title":"Front. Pharmacol."},{"issue":"11","key":"44971_CR16","doi-asserted-by":"publisher","first-page":"e2341936","DOI":"10.1001\/jamanetworkopen.2023.41936","volume":"6","author":"N Dave","year":"2023","unstructured":"Dave, N. et al. Nosocomial SARS-CoV-2 infections and mortality during unique COVID-19 epidemic waves. JAMA. Netw. Open. 6 (11), e2341936. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.41936 (2023).","journal-title":"JAMA. Netw. Open."},{"issue":"10","key":"44971_CR17","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.3390\/v14102292","volume":"14","author":"T Demuyser","year":"2022","unstructured":"Demuyser, T. et al. Healthcare-associated COVID-19 across five pandemic waves: Prediction models and genomic analyses. Viruses 14 (10), 2292. https:\/\/doi.org\/10.3390\/v14102292 (2022).","journal-title":"Viruses"},{"issue":"4","key":"44971_CR18","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.jhin.2020.10.006","volume":"106","author":"K Khonyongwa","year":"2020","unstructured":"Khonyongwa, K. et al. Incidence and outcomes of healthcare-associated COVID-19 infections: Significance of delayed diagnosis and correlation with staff absence. J. Hosp. Infect. 106 (4), 663\u2013672. https:\/\/doi.org\/10.1016\/j.jhin.2020.10.006 (2020).","journal-title":"J. Hosp. Infect."},{"issue":"5","key":"44971_CR19","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.jinf.2023.08.016","volume":"87","author":"SA Alpizar","year":"2023","unstructured":"Alpizar, S. A. et al. Molnupiravir for intra-household prevention of COVID-19: The MOVe-AHEAD randomized, placebo-controlled trial. J. Infect. 87 (5), 392\u2013402. https:\/\/doi.org\/10.1016\/j.jinf.2023.08.016 (2023).","journal-title":"J. Infect."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-44971-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-44971-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-44971-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T23:13:28Z","timestamp":1780960408000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-44971-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,16]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["44971"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-44971-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,16]]},"assertion":[{"value":"4 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was approved by the Ethical Board of Istanbul University Istanbul Medical School on 26.04.2022 with the registration number of 011-KAEK-57 \u2013 751. The work described has been carried out in accordance with The Code of Ethics of the World Medical Association.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"17754"}}